PDS Biotechnology Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +88.5% | +82.7% | -62.2% | +42.4% | +79.1% | +39.8% | -80.1% | +16.8% | +4.3% | +1.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +110.5% | +39.2% | +38.2% | -97.6% | +634.2% | +29.9% | +42.0% | +161.5% | -5.7% | -18.7% | -15.7% | |
| – | +83.4% | +69.6% | +20.2% | -19.1% | -23.2% | -38.1% | +49.9% | +20.2% | +22.7% | -10.2% | -7.2% | |
| – | +100.8% | +49.1% | +31.5% | -93.0% | +322.7% | -3.3% | +43.9% | +94.4% | +3.3% | -15.8% | -13.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +345.7% | +47.5% | +81.1% | -34.6% | -97.6% | -1.8% | -86.8% | +30,203.7% | +219.4% | +11.1% | +14.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.